# Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy

> **NCT04171466** · NA · COMPLETED · sponsor: **Seed Health** · enrollment: 46 (actual)

## Conditions studied

- Antibiotic Side Effect
- Antibiotic-associated Diarrhea
- Antibiotic-induced Dysbiosis
- Antibiotic-induced Epithelial Barrier Disintegrity

## Interventions

- **OTHER:** Ciprofloxacin + Metronidazole
- **OTHER:** SH-DS01
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04171466
- **Lead sponsor:** Seed Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-12
- **Primary completion:** 2022-09-07
- **Final completion:** 2022-09-07
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171466, "Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04171466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*